Chen R, Gillette J R
Laboratory of Chemical Pharmacology, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.
Drug Metab Dispos. 1988 May-Jun;16(3):373-85.
Several approaches have been developed to estimate in vivo the intrinsic clearances of enzymes that catalyze the formation of chemically reactive metabolites that do not escape the organs in which they are formed. Two basic models are considered. Model 1 is a general model in which the chemically reactive metabolite is inactivated by a combination of a pseudo-first order reaction, such as a reaction with large pools of protein, and a second order reaction with a depletable endogenous substance, such as glutathione or an enzyme. Model 2 is a special case, in which at low doses of the parent compound the reactive metabolite preferentially reacts with a depletable endogenous substance, such as glutathione. In developing both models we have assumed that the rate of formation of reactive metabolite follows first order kinetics and that the concentration of reactive metabolite in liver reaches a steady state almost instantaneously. In developing Model 2 we also have assumed that the depletion of hepatic reduced glutathione is due solely to the formation of glutathione conjugates. The uses of the approaches based on Model 2 were illustrated by studying the effects of a marginally toxic dose of acetaminophen on the depletion and subsequent repletion of hepatic glutathione in hamsters. From the calculated rate of synthesis of glutathione in liver, the fraction of the dose of acetaminophen converted to the glutathione conjugate in liver, and the clearance for the formation of glutathione conjugate in vivo was estimated and was found to be similar to that obtained with hepatic 9,000 g supernatant preparations. Other uses of the models are described.
已经开发了几种方法来体内估计催化化学反应性代谢物形成的酶的内在清除率,这些化学反应性代谢物不会逸出其形成的器官。考虑了两种基本模型。模型1是一个通用模型,其中化学反应性代谢物通过伪一级反应(如与大量蛋白质池的反应)和与可消耗内源性物质(如谷胱甘肽或酶)的二级反应的组合而失活。模型2是一种特殊情况,其中在低剂量母体化合物时,反应性代谢物优先与可消耗内源性物质(如谷胱甘肽)反应。在开发这两种模型时,我们假设反应性代谢物的形成速率遵循一级动力学,并且肝脏中反应性代谢物的浓度几乎瞬间达到稳态。在开发模型2时,我们还假设肝脏中还原型谷胱甘肽的消耗仅归因于谷胱甘肽共轭物的形成。通过研究对仓鼠肝脏谷胱甘肽的消耗和随后的补充,说明了基于模型2的方法的用途。从计算出的肝脏中谷胱甘肽的合成速率,估计了对乙酰氨基酚剂量中转化为肝脏中谷胱甘肽共轭物的部分,以及体内谷胱甘肽共轭物形成的清除率,发现其与用肝脏9000g上清液制剂获得的结果相似。还描述了模型的其他用途。